Phase I study of chimeric antigen receptor modified T cells in treating HER2-positive advanced biliary tract cancers and pancreatic cancers. (Q38677904)
Jump to navigation
Jump to search
scientific article published on 14 July 2017
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase I study of chimeric antigen receptor modified T cells in treating HER2-positive advanced biliary tract cancers and pancreatic cancers. |
scientific article published on 14 July 2017 |
Statements
Phase I study of chimeric antigen receptor modified T cells in treating HER2-positive advanced biliary tract cancers and pancreatic cancers (English)
Kaichao Feng
Yang Liu
Yelei Guo
Jingdan Qiu
Hanren Dai
Qingming Yang
Yao Wang
14 July 2017
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference